Kala Pharmaceuticals, Inc.
KALA
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-teā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.62
Price+7.55%
$0.04
1Y
Price
Market Cap
$4.369m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$254k
-
1y CAGR-33.3%
3y CAGR-41.3%
5y CAGREarnings
-$35.841m
+6.9%
1y CAGR+7.2%
3y CAGR+22.5%
5y CAGREPS
-$5.93
+15.0%
1y CAGR+38.7%
3y CAGR+47.3%
5y CAGRBook Value
-$8.665m
$25.021m
Assets$1.112m
Liabilities$29.943m
DebtDebt to Assets
119.7%
-1x
Debt to EBITDAFree Cash Flow
-$32.086m
-8.4%
1y CAGR+17.3%
3y CAGR+19.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company